<div class="container">

<table style="width: 100%;"><tr>
<td>select.mtd</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Select the maximum tolerated dose (MTD) for single agent trials</h2>

<h3>Description</h3>

<p>Select the maximum tolerated dose (MTD) when the single-agent trial is completed
</p>


<h3>Usage</h3>

<pre><code class="language-R">select.mtd(target, npts, ntox, cutoff.eli=0.95, extrasafe=FALSE, offset=0.05,
                 boundMTD=FALSE,p.tox=1.4*target)
</code></pre>


<h3>Arguments</h3>

<table>
<tr style="vertical-align: top;">
<td><code>target</code></td>
<td>
<p>the target DLT rate</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>npts</code></td>
<td>
<p>a vector containing the number of patients treated at each dose level</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>ntox</code></td>
<td>
<p>a vector containing the number of patients who experienced dose-limiting
toxicity at each dose level</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>cutoff.eli</code></td>
<td>
<p>the cutoff to eliminate overly toxic doses for safety. We recommend
the default value of (<code>cutoff.eli=0.95</code>) for general use.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>extrasafe</code></td>
<td>
<p>set <code>extrasafe=TRUE</code> to impose a more strict stopping rule for
extra safety</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>offset</code></td>
<td>
<p>a small positive number (between <code>0</code> and <code>0.5</code>) to control how strict the
stopping rule is when <code>extrasafe=TRUE</code>. A larger value leads to
a more strict stopping rule. The default value <code>offset=0.05</code>
generally works well.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>boundMTD</code></td>
<td>
<p>set <code>boundMTD=TRUE</code> to impose the condition: the isotonic estimate of toxicity
probability for the selected MTD must be less than de-escalation boundary.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>p.tox</code></td>
<td>
<p>the lowest toxicity probability that is deemed overly toxic such
that deescalation is required. The default value is
<code>p.tox=1.4*target</code>.</p>
</td>
</tr>
</table>
<h3>Details</h3>

<p><code>select.mtd()</code> selects the MTD based on isotonic estimates of toxicity
probabilities. <code>select.mtd()</code> selects as the MTD dose <code class="reqn">j^*</code>, for which the
isotonic estimate of the DLT rate is closest to the target. If there
are ties, we select from the ties the highest dose level when the estimate
of the DLT rate is smaller than the target, or the lowest dose level
when the estimate of the DLT rate is greater than the target. The
isotonic estimates are obtained by the pooled-adjacent-violators algorithm
(PAVA) (Barlow, 1972).
</p>


<h3>Value</h3>

<p><code>select.mtd()</code> returns (1) target toxicity probability (<code>$target</code>), (2) selected MTD (<code>$MTD</code>),
(3) isotonic estimate of the DLT probablity at each dose and associated <code class="reqn">95\%</code> credible interval (<code>$p_est</code>),
and (4) the probability of overdosing defined as <code class="reqn">Pr(toxicity&gt;\code{target}|data)</code> (<code>$p_overdose</code>)
</p>


<h3>Note</h3>

<p>The MTD selection and dose escalation/deescalation rule are two independent
components of the trial design. When appropriate, another dose selection
procedure (e.g., based on a fitted logistic model) can be used to select
the MTD after the completion of the trial using the BOIN design.
</p>


<h3>Author(s)</h3>

<p>Suyu Liu, Yanhong Zhou, and Ying Yuan
</p>


<h3>References</h3>

<p>Liu S. and Yuan, Y. (2015). Bayesian Optimal Interval Designs for
Phase I Clinical Trials, <em>Journal of the Royal Statistical Society:
Series C</em>, 64, 507-523.
</p>
<p>Yan, F., Zhang, L., Zhou, Y., Pan, H., Liu, S. and Yuan, Y. (2020).BOIN: An R Package
for Designing Single-Agent and Drug-Combination Dose-Finding Trials Using Bayesian Optimal
Interval Designs. <em>Journal of Statistical Software</em>, 94(13),1-32.&lt;doi:10.18637/jss.v094.i13&gt;.
</p>
<p>Yuan Y., Hess K.R., Hilsenbeck S.G. and Gilbert M.R. (2016). Bayesian Optimal Interval Design: A
Simple and Well-performing Design for Phase I Oncology Trials, <em>Clinical Cancer Research</em>, 22, 4291-4301.
</p>


<h3>See Also</h3>

<p>Tutorial: <a href="http://odin.mdacc.tmc.edu/~yyuan/Software/BOIN/BOIN2.6_tutorial.pdf">http://odin.mdacc.tmc.edu/~yyuan/Software/BOIN/BOIN2.6_tutorial.pdf</a>
</p>
<p>Paper: <a href="http://odin.mdacc.tmc.edu/~yyuan/Software/BOIN/paper.pdf">http://odin.mdacc.tmc.edu/~yyuan/Software/BOIN/paper.pdf</a>
</p>


<h3>Examples</h3>

<pre><code class="language-R">
### select the MTD for BOIN single agent trial
n &lt;- c(3, 3, 15, 9, 0)
y &lt;- c(0, 0, 4, 4, 0)
selmtd &lt;- select.mtd(target=0.3, npts=n, ntox=y)
summary(selmtd)
plot(selmtd)

</code></pre>


</div>